Chemocentryx reported $-21803000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amgen AMGN:US $ 2378M 1550M
AstraZeneca AZN:LN -1674000000 2.8B
Bayer BAYN:GR 530M 2.81B
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bristol Myers Squibb BMY:US $ 1996M 281M
Chemocentryx CCXI:US $ -21.8M 16.93M
Glaxosmithkline GSK:US $ 1938M 263M
GlaxoSmithKline GSK:LN 1.94B 263M
Johnson & Johnson JNJ:US $ 3849M 2813M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Novartis NOVN:VX 3.23B 246M
Omeros OMER:US $ -18253000 5.76M
Pfizer PFE:US $ 7647M 1733M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Takeda 4502:JP Y 97427M 151125M
Teva Pharmaceutical TEVA:IT 623M 41M
YTE INCY:US $ 235.41M 94.57M